共 50 条
- [31] Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymeraseJOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) : 39260 - 39267Kukolj, GMcGibbon, GAMcKercher, GMarquis, MLefèbvre, SThauvette, LGauthier, JGoulet, SPoupart, MABeaulieu, PL
- [32] Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug designEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 865 - 880Benmansour, FatihaTrist, IuniCoutard, BrunoDecroly, EtienneQuerat, GillesBrancale, AndreaBarral, Karine
- [33] Novel 4-Thiazolidinones as Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA PolymeraseARCHIV DER PHARMAZIE, 2015, 348 (01) : 10 - 22Cakir, GizemKucukguzel, IlkayGuhamazumder, RupaTatar, EsraManvar, DineshBasu, AmartyaPatel, Bhargav A.Zia, JavairiaTalele, Tanaji T.Kaushik-Basu, Neerja
- [34] Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) : 1205 - 1216Le Pogam, SophieSeshaadri, AmrithaKosaka, AlanChiu, SophieKang, HyunsoonHu, StevenRajyaguru, SonalSymons, JulianCammack, NickNajera, Isabel
- [35] NONCLINICAL AND CROSS-GENOTYPIC PROFILES OF GS-9669, A NOVEL HCV NS5B NON-NUCLEOSIDE THUMB SITE II INHIBITORJOURNAL OF HEPATOLOGY, 2011, 54 : S476 - S476Fenaux, M.Tian, Y.Matles, M.Mabery, E.Zhang, JingyuEng, S.Murray, B.Mwangi, J.Lazerwith, S.Lew, W.Canales, E.Liu, Q.Byun, D.Doerffler, E.Ye, H.Clarke, M.Mertzman, M.Morganelli, P.Zhang, JenniferLeavitt, S.Appleby, T.Hashash, A.Bidgood, A.Krawczyk, S.Watkins, W.
- [36] Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymeraseBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (18) : 4536 - 4541Rouviere, Claire PierraAmador, AgnesBadaroux, EricConvard, ThierryDa Costa, DanielDukhan, DavidGriffe, LudovicGriffon, Jean-FrancoisLaColla, MassimilianoLeroy, FredericLiuzzi, MichelLoi, Anna GiuliaMcCarville, JoeMascia, ValeriaMilhau, JulienOnidi, LoredanaPaparin, Jean-LaurentRahali, RachidSais, EfisioSeifer, MariaSurleraux, DominiqueStandring, DavidDousson, Cyril
- [37] Pharmacokinetics and Drug-Drug Interaction between Samatasvir, an NS5A Inhibitor, and Co-administered Simeprevir, an NS3/4A Protease Inhibitor, and Low Dose Ritonavir-Boosted TMC647055, a Non-Nucleoside NS5B Inhibitor, in Healthy Volunteers and HCV-Infected SubjectsHEPATOLOGY, 2014, 60 : 1167A - 1168AZhou, Xiao-JianPietropaolo, KeithFrank, DodieChen, Jievan Heeswijk, RolfSullivan-Bolyai, JohnVan Remoortere, PieterVerloes, ReneMayers, Douglas L.
- [38] Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistryScientific Reports, 7Armando LagruttaChristopher P. ReganHaoyu ZengJohn P. ImredyKenneth KoeplingerPierre MorissetteLiping LiuGordon WollenbergChristopher BrynczkaJosé LebrónJoseph DeGeorgeFrederick Sannajust
- [39] Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistrySCIENTIFIC REPORTS, 2017, 7Lagrutta, ArmandoRegan, Christopher P.Zeng, HaoyuImredy, John P.Koeplinger, KennethMorissette, PierreLiu, LipingWollenberg, GordonBrynczka, ChristopherLebron, JoseDeGeorge, JosephSannajust, Frederick
- [40] Structural Basis for Resistance of the Genotype 2b Hepatitis C Virus NS5B Polymerase to Site A Non-Nucleoside InhibitorsJOURNAL OF MOLECULAR BIOLOGY, 2009, 390 (05) : 1048 - 1059Rydberg, Edwin H.Cellucci, AntonellaBartholomew, LindaMattu, MarcoBarbato, GaetanoLudmerer, Steven W.Graham, Donald J.Altamura, SergioPaonessa, GiacomoDe Francesco, RaffaeleMigliaccio, GiovanniCarfi, Andrea